Alzheimer's drug shows promising results in trial study
The company is already seeking an accelerated approval from the U.S. Food and Drug Administration, and the agency is expected to decide by early next year.
United Kingdom Eli Lilly Graig Suvannavejh Research Memory Centre Claude Pompidou Institute Japan Eisai Co
Source: fox10phoenix.com